
IM PGY-1 @FIUMedicine | Former Scientist @Umiamimedicine and research fellow @Hopkinsmedicine 🇺🇸 | MD @UIS 🇨🇴 | He/Him/His | 🩺🏥 🧬 🏃🏻 ✈️
Miami, FL
Joined May 2011
- Tweets1.4K
- Following564
- Followers272
- Likes2.1K
Among adults with septic shock, the use of restricted fluids and early vasopressors did not result in more days alive and out of the hospital through day 90 than the use of liberal fluids and later vasopressors. Full ARISE FLUIDS trial results and Research Summary: nej.md/3PVdwIp

ALT This image contains an excerpt from the Research Summary "Vasopressors or Fluids in Early Septic Shock” published in the New England Journal of Medicine. It includes a depiction of a patient with septic shock. The summary outlines a study with 1000 adults, median age 68, 60% men, and 40% women. Two groups are compared: "Vasopressor Group," with restricted fluids and early vasopressors, and "Fluids Group," with liberal fluids and later vasopressors. There are illustrations representing each group. A prompt to read the full Research Summary at NEJM.org sits at the bottom.
Andrés Villabona-Rueda retweeted
Use this free patient summary to help explain the new U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for #tobacco use treatment. bit.ly/3VLhCoM
Andrés Villabona-Rueda retweeted
Original research findings indicate that the ventilator-associated pneumonia (VAP) risk score allows daily stratification of VAP risk in patients receiving ventilation for ≥ 48 hours using six clinical variables.
Read more in #Journal_CHESTCritCare: hubs.la/Q04w4q5_0
#MedEd #JournalCHEST #CriticalCare #CritCare #Pneumonia
Andrés Villabona-Rueda retweeted
📣 Sepsis Webinar in Spanish
Join CHEST and the Asociación Latinoamericana de Tórax Monday, September 21, at 6 pm CT, for a Spanish-language webinar on the latest in sepsis and ARDS.
English captions available
🔗Register: hubs.la/Q04xHkxW0
Andrés Villabona-Rueda retweeted
Skin diseases affect far more than what we can see.
A new Editorial examines how advances in dermatology can deliver greater clinical benefit—from more representative clinical trials to better measurement of stigma and quality of life.
Read this & more: spkl.io/601973DaJ
Andrés Villabona-Rueda retweeted
A new Annals #InTheClinic feature outlines evidence-based strategies for health care maintenance in the outpatient management of adults with #InflammatoryBowelDisease. bit.ly/4wT4hbR
Syncope, or a fainting episode, is defined as a transient loss of consciousness accompanied by an inability to maintain postural tone, resulting from temporary cerebral hypoperfusion, which is followed by rapid and spontaneous recovery. Learn more in a new article: nej.md/4cjFuVU
Closing an unforgettable 8-year chapter with my research family 🥹 from Johns Hopkins to the University of Miami. Thank you for everything 🙏🏼 Excited for the next chapter #Medicine #Science @DAlessioLab @RDamicoJHHPH
1
7
282
Andrés Villabona-Rueda retweeted
📆📆📆Part 2 of the ATS AII Abstract scholarship awardee presentations is coming up fast. Use the ATS website to register now! See you on 10/17/25 at 1100EST!
@ATS_Assemblies @atscommunity
Andrés Villabona-Rueda retweeted
Patterns of nodularity on CT from our most recent Fellows' Case Files from KUMC
pulmpeeps.com/2025/10/01/107…
Apple: podcasts.apple.com/us/podcas…
Spotify: open.spotify.com/episode/75D…
Amazon:
music.amazon.com/podcasts/91…
Andrés Villabona-Rueda retweeted
BREAKING NEWS
The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
Andrés Villabona-Rueda retweeted
Breathe: Idiopathic pulmonary fibrosis and progressive pulmonary fibrosis are characterised by progressive fibrosis and share common pathophysiological pathways that have led to the study of promising new therapeutic targets. bit.ly/3RdJRqA
Andrés Villabona-Rueda retweeted
The Heterogeneity, Parallels, and Divergence of Alveolar Macrophages in Humans and Mice
@atscommunity
🔗 tinyurl.com/yb66ch6e
Andrés Villabona-Rueda retweeted
International Medical Graduates Are Integral to the Delivery of Patient Care in the United States | Annals of Internal Medicine acpjournals.org/doi/10.7326/…
Andrés Villabona-Rueda retweeted
Special Stains in Histopathology 🔬
polysciences.com/german/cata…
Andrés Villabona-Rueda retweeted
Scientists should get paid for thinking time @Nature
#PhD #PhDlife #academics #AcademicChatter #AcademicTwitter #Postdocs #Research #Science
And here we are! Doing science until the very last day! Will miss this awesome crew (this centrifuge of course ) 🤣
@romyrod @DrGhanbar #Physician #Scientist #Pulmonary #Medicine #Hopkins #PCCM
A well deserved coffee after multiple poster presentations at ATS. Such a busy day! ☕️ #CoffeeLovers #LatinoEnUSA #IMGs @romyrod @HopkinsPCCM @JHUPCCMFellows
Excited to share our preliminary results related to the different gene and protein signature of alveolar and bone marrow derived macrophages at ATS! 🫁 #Physician #Scientist #Medicine @RDamicoJHHPH @DAlessioLab @JHUPCCMFellows @HopkinsMedicine


































